Ontology highlight
ABSTRACT:
SUBMITTER: Borget I
PROVIDER: S-EPMC4302067 | biostudies-literature | 2014 Dec
REPOSITORIES: biostudies-literature
Borget Isabelle I Pérol Maurice M Pérol David D Lavolé Armelle A Greillier Laurent L Dô Pascal P Westeel Virginie V Crequit Jacky J Léna Hervé H Monnet Isabelle I Le Caer Hervé H Fournel Pierre P Falchero Lionel L Poudenx Michel M Vaylet Fabien F Chabaud Sylvie S Vergnenegre Alain A Zalcman Gérard G Chouaïd Christos C
BMC cancer 20141215
<h4>Background</h4>The IFCT-GFPC 0502 phase III study reported prolongation of progression-free survival with gemcitabine or erlotinib maintenance vs. observation after cisplatin-gemcitabine induction chemotherapy for advanced non-small-cell lung cancer (NSCLC). This analysis was undertaken to assess the incremental cost-effectiveness ratio (ICER) of these strategies for the global population and pre-specified subgroups.<h4>Methods</h4>A cost-utility analysis evaluated the ICER of gemcitabine or ...[more]